These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26482818)

  • 1. Interactive Volumetry Of Liver Ablation Zones.
    Egger J; Busse H; Brandmaier P; Seider D; Gawlitza M; Strocka S; Voglreiter P; Dokter M; Hofmann M; Kainz B; Hann A; Chen X; Alhonnoro T; Pollari M; Schmalstieg D; Moche M
    Sci Rep; 2015 Oct; 5():15373. PubMed ID: 26482818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RFA-cut: Semi-automatic segmentation of radiofrequency ablation zones with and without needles via optimal s-t-cuts.
    Egger J; Busse H; Brandmaier P; Seider D; Gawlitza M; Strocka S; Voglreiter P; Dokter M; Hofmann M; Kainz B; Chen X; Hann A; Boechat P; Yu W; Freisleben B; Alhonnoro T; Pollari M; Moche M; Schmalstieg D
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2423-9. PubMed ID: 26736783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation: a new therapeutic modality for the management of hepatocellular cancer.
    Gulati MS; Batra Y; Paul SB; Madan K; Ahuja V; Kaul HK
    Trop Gastroenterol; 2002; 23(4):183-5. PubMed ID: 12833706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatocellular carcinoma using internally cooled electrodes. A prospective comparison of modified automated vs. manual pulsed radiofrequency algorithms.
    Cua IH; Lin CC; Lin CJ; Chen WT; Hsu CW; Chen YC; Wong SN; Lin SM
    Oncology; 2007; 72 Suppl 1():76-82. PubMed ID: 18087186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An automatic registration method for pre- and post-interventional CT images for assessing treatment success in liver RFA treatment.
    Luu HM; Klink C; Niessen W; Moelker A; van Walsum T
    Med Phys; 2015 Sep; 42(9):5559-67. PubMed ID: 26329002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
    AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.
    Lee MW; Kim YJ; Park SW; Hwang JH; Jung SI; Jeon HJ; Kwon WK
    Br J Radiol; 2009 Nov; 82(983):908-15. PubMed ID: 19433482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma.
    Allgaier HP; Deibert P; Zuber I; Olschewski M; Blum HE
    Lancet; 1999 May; 353(9165):1676-7. PubMed ID: 10335793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current role of minimally invasive therapies in the management of liver tumors.
    Rempp H; Boss A; Helmberger T; Pereira P
    Abdom Imaging; 2011 Dec; 36(6):635-47. PubMed ID: 21562884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.